The use and the cost of outpatient diagnostic procedures for cardiovascular diseases in Isfahan province: A utilization study
Volume 12, Issue 6, July 2022, Pages 1-7
. Reza Rezayatmand, . Ghasem Yadegarfar, . Masoumeh Ghasemirad, . Farzaneh Mohammadi
Abstract BACKGROUND: Cardiovascular diseases (CVDs) are among the most important causes of premature
death, disability, disease burden, and increasing the cost of healthcare worldwide. Having an overview
of service utilization can help policymakers to plan more effective use of those services and to cut
costs. Thus, this study aims to determine the amount of use as well as the cost of various outpatient
diagnostic procedures for CVDs in Isfahan province of Iran from 2011 to 2017.
MATERIALS AND METHODS: This descriptive study used insurance claim data (time period:
2011–2017) from Health Insurance Organization in Isfahan province to determine the amount of
use and the cost of various outpatient diagnostic procedures for CVDs. Afterward, based on these
data, the use and the cost of various outpatient diagnostic procedures for CVDs were estimated for
the total population of Isfahan province. The list of outpatient diagnostic procedures for CVDs was
carefully chosen according to experts’ opinions.
RESULTS: The use and the cost of outpatient diagnostic procedures for CVDs have drastically
increased in the study period (2011–2017). Since 2011, the number of procedures and their related
costs have increased 6.6 and 30.76 times (11.74 times, adjusted with PPP conversion factor),
respectively. Per capita use (per thousand people) was 18.75 in 2011, reaching 116.51 in 2017.
Per capita cost (per thousand people) was 1,887,660 IRR (355 PPP$) in 2011, reaching 54,660,365
IRR (3920 PPP$) in 2017. The highest cost and use were related to echocardiography and
electrocardiography, respectively. A notable increase has been observed in the share of radionuclide
myocardial perfusion scan and analysis of pacemakers and ICDs of the total cost.
CONCLUSIONS: The use of outpatient diagnostic procedures for CVDs has drastically increased
during the studied period. Consequently, the cost borne by the health system and the patients have
notably increased. This may be because of the increase in the incidence and prevalence of CVDs
during the study period. Greater access to related health services can be mentioned as another reason
for this increase. Further research is needed to explain all potential reasons and their importance,
which can provoke a suitable health policy reaction.
